Quarterly Sales and EPS Roundup:
AbbVie Inc. (ABBV) reported sales (ttm) of 26.22 Billion, whereas, 14 number of analysts estimated the mean sale of 6903.43 million. The analysts estimated sales for the higher end at 7074.8 million and lower end at 6773 million while the year ago reported sale was 7047 million.
14 number of analysts have estimated the sales of the company for the quarter, analysts estimated mean sale target of 7392.72 million while high and low sale targets are estimated at 7531 million and 7310 million respectively.
AbbVie Inc. (ABBV) reported earning per shares for the quarter ending Jul 28 BMO, whereas, 17 number of analysts estimated the mean EPS at 1.4. The analysts estimated EPS for the higher end at 1.46 and lower end at 1.34 while the year ago reported earnings per share was 1.5.
The company has mean EPS estimate of 1.44 reported by 17 number of analyst for the quarter ending Current Qtr.(Jun2017). The analysts estimated mean EPS at 1.44 while the high and low EPS estimate stand at 1.51 and 1.4 respectively. In contrast to the year ago quarter EPS was at 1.54. EPS long term mean growth rate estimated by 8 analysts is at 14.44%, whereas, the high and low Long term growth rate estimated at 18 and 9.
Valuation Ratios of AbbVie Inc. (ABBV) versus the Industry and Sector:
Let’s have a look at some of the important valuation ratios of the AbbVie Inc. (ABBV). These ratios are important while doing valuation of the company or the shares of the company.
AbbVie Inc. (ABBV) currently has P/E (Price to Earnings) ratio of 18.82 while the company’s industry has 13.61 P/E and the sector P/E is 17.23. Similarly, the company’s last 5 years high P/E ratio is 59.39 and low P/E is 10.21, whereas, the industry’s and sector’s high P/E for the past year is 39.92 and 43.61 respectively and low P/E ratio for the last 5 years is 22.77 for the industry and 23.34 for the Sector.
Beta is also an important valuation ratio for analyzing the stock of the company, ABBV has Beta of 1.53 while its industry and Sector’s beta remains at 0.91 and 0.89 respectively.
Price to Sale ratio of ABBV stands at 4.44 while Price to Book Ratio stands at 23.28. Its Price to Cash Flow ratio shows the value of 15.3, whereas, the industry and sector ratio of Price to Cash Flow ticked at 8.7 and 10.42 respectively.
5 Year Growth Rate Analysis:
Growth rates are very important while analyzing the long term growth and valuation of a certain company.
5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of AbbVie Inc. (ABBV) stands at 8.01 while the industry’s and the sector’s growth for next 5 years ticked at 10.36 and 10.49 respectively. The company’s 5 year Earnings per share growth and Capital Spending growth remains at 10.94 and 6.14.
AbbVie Inc. (ABBV) Trading Statistics:
The company surged 0.66% and closed its last trading session at $72.63. The market capitalization of the company is at $116.76 Billion. The stock touched 52-week High of $73.67 on 06/22/17 and 52-week Low of $55.06 on 10/28/16. The stock currently has Weekly Volatility of 1.19% and Monthly Volatility of 1.21%. The Beta for the company stands at 1.53 and its Average True Range (ATR) shows a value of 0.89.